EXACT SCIENCES CORP — Director's Dealing 2016

Nov 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2016-11-11

Reporting Person: Conroy Kevin T (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-11	Common Stock	M	600000	$0.83	Acquired	1340057	Direct
2016-11-11	Common Stock	S	50000	$17.68	Disposed	1290057	Direct
2016-11-14	Common Stock	S	275000	$17.52	Disposed	1015057	Direct
2016-11-15	Common Stock	S	275000	$17.36	Disposed	740057	Direct
2016-11-15	Common Stock	M	33075	$9.07	Acquired	773132	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-11	Stock Option (right to buy)	$0.83	M	600000	Disposed	2019-03-18	Common Stock (1618076)	Direct
2016-11-15	Stock Option (right to buy)	$9.07	M	33075	Disposed	2022-02-27	Common Stock (127500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23513	Indirect
Common Stock	65189	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.60 to $17.75, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.10 to $17.79, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.20 to $17.56, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.